Dyadic International, Inc. (DYAI) is a Healthcare stock trading at $0.70 (as of 2026-08-21), with a market capitalization of $25.49M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Dyadic International, Inc. (business description not provided) generates revenue and reports gross margin of 28.7%, but it is currently loss-making at the operating level (operating margin -171.3%).
The profit model is currently characterized by operating expenses that exceed gross profit, leading to a deeply negative operating margin.
Business quality (Weak): Material company-level detail is missing in the provided facts, including the business description, reportable operating segments, and any operating KPIs.
| Price | $0.70 |
| Market Cap | $25.49M |
| Price / Sales | 5.86 |
| Revenue (TTM) | $3.09M |
| Net Margin | -238.3% |
| Revenue Growth (YoY) | -11.6% |
| EPS Growth (YoY) | 15.0% |
| Altman Z-Score | -12.73 (distress) |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector | Healthcare |
| Industry | Pharmaceutical Products |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.